ProPhet Bio Ltd.
Biomed — Stage: R&D. Est: 2024. Tags: Artificial Intelligence, Biologicals, Biotechnology, Drug Discovery, Large Language Model (LLM), Life Sciences, Machine Learning, MedTech. ProPhet is an AI-driven company, transforming small molecule drug discovery with a focus on proteins that are hard to target. The company develops advanced technology to identify potential therapeutics for these challenging targets, addressing a need in the pharmaceutical industry. ProPhet's AI platform evaluates vast libraries of small molecules, offering faster, more efficient and cost-effective solutions, this helps pharmaceutical companies and researchers explore a broader range of treatments with more accuracy. The company also is about to reduce the time and cost of finding molecules that can be used as drugs with the help of artificial intelligence. Its novel technology knows how to match molecules to proteins with the help of smart AI models, significantly simplifying the process.. Web: https://pro-phet.com